Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Today is the LAST DAY of this Mid-Year Campaign. This is our hour of need.
If you value independent journalism, please support Common Dreams.

TODAY is the last day to meet our goal -- Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year.

President Donald Trump holds a news conference about the ongoing global coronavirus pandemic in the Rose garden at the White House March 13, 2020 in Washington, D.C. (Photo: Drew Angerer/Getty Images)

'Depraved': Trump Reportedly Offered German Firm 'Large Sum' for Exclusive Rights to Coronavirus Vaccine

"Trump wanted not only to control any new vaccine but also to make sure that it would only be available on a for-profit basis."

Jake Johnson

German lawmakers and government officials voiced outrage at reporting Sunday that the Trump administration is seeking to secure exclusive rights to a potential coronavirus vaccine being developed by the German firm CureVac as the pandemic spreads and takes lives across the globe.

The German newspaper Welt am Sonntag, citing an anonymous German government official, reported Sunday that the Trump administration offered CureVac $1 billion to hand the U.S. exclusive rights to a potential COVID-19 vaccine.

Trump wants the vaccine "only for the USA," the German official said. The New York Times confirmed late Sunday that the Trump administration attempted to persuade CureVac to move its research to the U.S., offering the company what one German official described as a "large sum" of money.

"Germany is not for sale," economy minister Peter Altmaier declared in response to the bombshell reporting, which White House officials said was overblown.

"International cooperation is important now, not national self-interest," said conservative lawmaker Erwin Rueddel, a member of the German parliament's health committee.

Led by Chancellor Angela Merkel, German government ministers on Monday are planning to convene a crisis meeting that will include discussion of CureVac, which is headquartered in Tübingen, Germany but also has an office in Boston, Massachusetts.

"Top White House aides were unaware of any communication by or offer from President Trump to CureVac," the Washington Post reported, citing an anonymous administration official. "The official cautioned, however, that Trump often has private conversations of which his staff is not aware, and therefore the official could not definitively rule out that any such discussion had occurred."

The Trump administration has faced backlash for refusing to vow that any COVID-19 vaccine will be affordable for all in the U.S.—let alone free, as progressives and public health experts are demanding.

"We would want to ensure that we'd work to make it affordable, but we can't control that price because we need the private sector to invest," U.S. Health and Human Services Secretary Alex Azar said during a congressional hearing last month.

Reuters reported Sunday that CureVac has "started with a multitude of coronavirus vaccine candidates and was now selecting the two best to go into clinical trials."

"The privately-held company... hopes to have an experimental vaccine ready by June or July to then seek the go-ahead from regulators for testing on humans," Reuters noted.

Christof Hettich, chief executive of Dievini Hopp Biotech Holding, CureVac's main investor, told the German newspaper Mannheimer Morgen on Sunday that it has no plans to allow any nation to purchase exclusive rights to a potential COVID-19 vaccine.

"We want to develop a vaccine for the whole world, and not for individual countries," said Hettich.


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

TODAY is the last day of our crucial Mid-Year Campaign and we might not make it without your help.
Who funds our independent journalism? Readers like you who believe in our mission: To inform. To inspire. To ignite change for the common good. No corporate advertisers. No billionaire founder. Our non-partisan, nonprofit media model has only one source of revenue: The people who read and value this work and our mission. That's it.
And the model is simple: If everyone just gives whatever amount they can afford and think is reasonable—$3, $9, $29, or more—we can continue. If not enough do, we go dark.

All the small gifts add up to something otherwise impossible. Please join us today. Donate to Common Dreams. This is crunch time. We need you now.

Texas Supreme Court Allows Century-Old Abortion Ban to Take Effect

"Extremist politicians are on a crusade to force Texans into pregnancy and childbirth against their will, no matter how devastating the consequences."

Jake Johnson ·


'What's There to Even Discuss?' Omar Says Free, Universal School Meals Should Be Permanent

"We have an opportunity to prove that a government of the people, by the people, and for the people can still deliver big things. And we can feed tens of millions of hungry kids while we do it."

Jake Johnson ·


'Stark Betrayal': Biden Administration Floats New Offshore Oil and Gas Drilling

"This is the third time since November the Biden administration has announced new oil and gas leasing plans on the Friday before a holiday," said one climate advocate. "They're ashamed, and they should be."

Jake Johnson ·


As US Rolls Back Reproductive Rights, Sierra Leone Moves to Decriminalize Abortion

"I'm hopeful today's announcement gives activists in the U.S., and especially Black women given the shared history, a restored faith that change is possible and progress can be made."

Brett Wilkins ·


'Indefensible': Outrage as New Reporting Shines Light on Biden Deal With McConnell

The president has reportedly agreed to nominate an anti-abortion Republican to a lifetime judgeship. In exchange, McConnell has vowed to stop blocking two Biden picks for term-limited U.S. attorney posts.

Jake Johnson ·

Common Dreams Logo